Shopping Cart 0
Cart Subtotal
USD 0

Neurodegenerative Disorder Therapeutics Market Global Report 2020-30

Bundle Purchase

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 4000

Access to Printed Report; No Soft Copy
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : Printed Publication/ Book by Post

Hard Copy License
USD 4000

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 6000

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

CD-Rom
USD 4000

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 8000

Details

The neurodegenerative disorder therapeutics market consists of sales of neurodegenerative disorder therapeutics products and related services for neurodegenerative disorders. Neurodegenerative disorder is a range of incurable conditions that primarily affect the neurons of human brain and results in progressive degeneration or death of nerve cells. The neurodegenerative disorder therapeutics deals with the manufacturing and development of drugs and treatment that stops or slows down the neurodegenerative processes of diseases such as Parkinson's, Alzheimer's, Huntington's and other neurodegenerative disorders.
 
The global neurodegenerative disorder therapeutics market was worth USD 13.35 billion in 2019. It is expected to grow at a compound annual growth rate (CAGR) of 8.12% and reach USD 18.23 billion by 2023.
 
The neurodegenerative disorder therapeutics market has been geographically segmented into North America, Western Europe, Asia-Pacific, Eastern Europe, South America and Middle East & Africa. North America was the largest region in 2019 and Europe was the fastest growing region in 2019.
 
The neurodegenerative disorder therapeutics market covered in this report is segmented by indication type into Parkinson's disease, Alzheimer's disease, multiple sclerosis, Huntington disease, other indications. It is also segmented by drug type into n- methyl- d- aspartate receptor, selective serotonin reuptake inhibitor, dopamine inhibitors, others and by distribution into hospital pharmacy, retail pharmacy, online pharmacy.
 
Increased prevalence of neurodegenerative among the global population contributes to the growth of neurodegenerative disorder therapeutics market. The increase in the number of geriatric population, attributes to the increased prevalence of neurodegenerative disorders. According to World Population Prospects in 2017, the number of people above 60 years of age will increase from 962 million in 2017 to 2.1 billion in 2050 and it is expected that people aged over 80 years will triple from 137 million in 2017 to 425 million in 2050. According to the Alzheimer's Association, around 5.8 million Americans are suffering with Alzheimer disease and this number is projected to rise to around 14 million by 2050. The increased prevalence of neurodegenerative diseases among the ageing population increases the demand for neurodegenerative disorder therapeutics thereby driving the market.
 
High rates of failure in clinical trials and research and development (R&D) have always been a major challenge in the neurodegenerative disorder therapeutics market. Companies are continuously investing in R&D to develop treatments for neurodegenerative diseases but currently very few treatments are approved for neurodegenerative disorders. According to a study, researchers found out that between 2002 to 2012, only 244 compounds in 413 clinical trials for Alzheimer's disease passed through but only one compound was approved. This failure entitled Alzheimer's disease drugs to the highest rates of failure at 99.6% when compared to any other disease, including cancer, which has a failure rate at 81%. Moreover, as reported by The New England Journal of Medicine, in 2018, no new drug has been approved by the Food and Drug Administration (FDA) to treat Alzheimer's disease since 2013. The low rate of approval of neurodegenerative therapeutics have a negative impact on the market, hindering the growth of the market.
 
Manufacturers of neurodegenerative disorder therapeutics are undergoing various strategic partnerships with government and non- government organizations to discover and develop therapeutics for a range of neurodegenerative diseases. The companies in the neurodegenerative disorder therapeutics market are also increasing their collaboration with other players in the market in order to increase their capabilities for research and development activities in order to develop new and more effective therapeutic solutions to treat neurodegenerative disorders. For instance, from October 2019, Prevail Therapeutics Inc., a USA based biotechnology company and Lonza, a global supplier of pharma & Biotech and specialty ingredients based in Switzerland, collaborated to develop and manufacture gene therapy programs for patients of neurodegenerative diseases. Similarly, in February 2018, Abbevie, a USA based biopharmaceutical company and Voyager Therapeutics, a clinical stage gene therapy company based in USA, underwent a global strategic collaboration to develop and commercialize treatments for Alzheimer's disease and other tau-related (a protein) neurodegenerative diseases.
 
In January 2020, Biogen Inc., an America Biotechnology company acquired a novel clinical stage asset, PF-05251749 alongwith the applications from Pfizer for USD 75 million. The acquisition of the asset is expected to strengthen Biogen's existing pipeline of potential disease-modifying therapies in Alzheimer's and Parkinson's diseases since PF-05251749 is a CNS- penetrant regulator that has the potential to treat behavioral and neurological symptoms across various psychiatric and neurological diseases. Pfizer Inc., is a multinational pharmaceutical company based in the USA.
 
Major players in the market are Biogen, Pfizer, Novartis, Sanofi, Teva Pharmaceutical, UCB, Hoffmann- La Roche Ltd, ACADIA Pharmaceuticals Inc., Lundeck A/S and Boehringer Ingeiheim International GmbH.
READ MORE

Table Of Content

Scope

1. Executive Summary

2. Neurodegenerative Disorder Therapeutics Market Characteristics

3. Neurodegenerative Disorder Therapeutics Market Size And Growth

3.1. Global Neurodegenerative Disorder Therapeutics Historic Market, 2015-2019, USD Billion

3.1.1. Drivers Of The Market

3.1.2. Restraints On The Market

3.2. Global Neurodegenerative Disorder Therapeutics Forecast Market, 2019-2023F, 2025F, 2030F, USD Billion

3.2.1. Drivers Of The Market

3.2.2. Restraints On the Market

4. Neurodegenerative Disorder Therapeutics Market Segmentation

4.1. Global Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Parkinson's Disease

Alzheimer's Disease

Multiple Sclerosis

Huntington Disease

Other Indication Types

4.2. Global Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

N- methyl- D- aspartate Receptor

Selective Serotonin Reuptake Inhibitor

Dopamine Inhibitors

Other Drug Types

4.3. Global Neurodegenerative Disorder Therapeutics Market, Segmentation By Distribution, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

5. Neurodegenerative Disorder Therapeutics Market Regional And Country Analysis

5.1. Global Neurodegenerative Disorder Therapeutics Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

5.2. Global Neurodegenerative Disorder Therapeutics Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

6. Asia-Pacific Neurodegenerative Disorder Therapeutics Market

6.1. Asia-Pacific Neurodegenerative Disorder Therapeutics Market Overview

6.2. Asia-Pacific Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

6.3. Asia-Pacific Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

7. China Neurodegenerative Disorder Therapeutics Market

7.1. China Neurodegenerative Disorder Therapeutics Market Overview

7.2. China Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,USD Billion

7.3. China Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,USD Billion

8. India Neurodegenerative Disorder Therapeutics Market

8.1. India Neurodegenerative Disorder Therapeutics Market Overview

8.2. India Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

8.3. India Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

9. Japan Neurodegenerative Disorder Therapeutics Market

9.1. Japan Neurodegenerative Disorder Therapeutics Market Overview

9.2. Japan Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

9.3. Japan Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

10. Australia Neurodegenerative Disorder Therapeutics Market

10.1. Australia Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

10.2. Australia Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

11. Indonesia Neurodegenerative Disorder Therapeutics Market

11.1. Indonesia Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

11.2. Indonesia Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

12. South Korea Neurodegenerative Disorder Therapeutics Market

12.1. South Korea Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

12.2. South Korea Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

13. Western Europe Neurodegenerative Disorder Therapeutics Market

13.1. Western Europe Neurodegenerative Disorder Therapeutics Market Overview

13.2. Western Europe Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

13.3. Western Europe Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

14. UK Neurodegenerative Disorder Therapeutics Market

14.1. UK Neurodegenerative Disorder Therapeutics Market Overview

14.2. UK Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

14.3. UK Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

15. Germany Neurodegenerative Disorder Therapeutics Market

15.1. Germany Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

15.2. Germany Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

16. France Neurodegenerative Disorder Therapeutics Market

16.4. France Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

16.5. France Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

17. Eastern Europe Neurodegenerative Disorder Therapeutics Market

17.1. Eastern Europe Neurodegenerative Disorder Therapeutics Market Overview

17.2. Eastern Europe Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

17.3. Eastern Europe Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

18. Russia Neurodegenerative Disorder Therapeutics Market

18.1. Russia Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

18.2. Russia Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

19. North America Neurodegenerative Disorder Therapeutics Market

19.1. North America Neurodegenerative Disorder Therapeutics Market Overview

19.2. North America Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

19.3. North America Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

20. USA Neurodegenerative Disorder Therapeutics Market

20.1. USA Neurodegenerative Disorder Therapeutics Market Overview

20.2. USA Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

20.3. USA Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

21. South America Neurodegenerative Disorder Therapeutics Market

21.1. South America Neurodegenerative Disorder Therapeutics Market Overview

21.2. South America Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

21.3. South America Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

22. Brazil Neurodegenerative Disorder Therapeutics Market

22.1. Brazil Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

22.2. Brazil Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

23. Middle East Neurodegenerative Disorder Therapeutics Market

23.1. Middle East Neurodegenerative Disorder Therapeutics Market Overview

23.2. Middle East Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

23.3. Middle East Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

24. Africa Neurodegenerative Disorder Therapeutics Market

24.1. Africa Neurodegenerative Disorder Therapeutics Market Overview

24.2. Africa Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

24.3. Africa Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

25. Neurodegenerative Disorder Therapeutics Market Competitive Landscape And Company Profiles

25.1. Neurodegenerative Disorder Therapeutics Market Competitive Landscape

25.2. Neurodegenerative Disorder Therapeutics Market Company Profiles

25.2.1. Biogen

25.2.1.1. Overview

25.2.1.2. Products and Services

25.2.1.3. Strategy

25.2.1.4. Financial Performance

25.2.2. Pfizer

25.2.2.1. Overview

25.2.2.2. Products and Services

25.2.2.3. Strategy

25.2.2.4. Financial Performance

25.2.3. Novartis

25.2.3.1. Overview

25.2.3.2. Products and Services

25.2.3.3. Strategy

25.2.3.4. Financial Performance

25.2.4. Sanofi

25.2.4.1. Overview

25.2.4.2. Products and Services

25.2.4.3. Strategy

25.2.4.4. Financial Performance

25.2.5. Teva Pharmaceutical

25.2.5.1. Overview

25.2.5.2. Products and Services

25.2.5.3. Strategy

25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Neurodegenerative Disorder Therapeutics Market

27. Neurodegenerative Disorder Therapeutics Market Trends And Strategies

28. Neurodegenerative Disorder Therapeutics Market Future Outlook and Potential Analysis

29. Appendix

29.1. Abbreviations

29.2. Currencies

29.3. Research Inquiries

29.4. The Business Research Company

29.5. Copyright And Disclaimer

 


List Of Figure

Figure 1: Global Historic Market Growth, 2015-2019, USD Billion

Figure 2: Global Forecast Market Growth, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 3: Global Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 4: Global Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 5: Global Neurodegenerative Disorder Therapeutics Market, Segmentation By Distribution, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 6: Global Neurodegenerative Disorder Therapeutics Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 7: Global Neurodegenerative Disorder Therapeutics Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 8: Asia-Pacific, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 9: Asia-Pacific, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 10: China, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 11: China, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 12: India, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 13: India, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 14: Japan, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 15: Japan, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 16: Australia, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 17: Australia, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 18: Indonesia, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 19: Indonesia, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 20: South Korea, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 21: South Korea, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 22: Western Europe, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 23: Western Europe, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 24: UK, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 25: UK, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 26: Germany, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 27: Germany, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 28: France, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 29: France, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 30: Eastern Europe, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 31: Eastern Europe, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 32: Russia, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 33: Russia, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 34: North America, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 35: North America, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 36: USA, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 37: USA, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 38: South America, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 39: South America, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 40: Brazil, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 41: Brazil, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 42: Middle East, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 43: Middle East, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 44: Africa, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 45: Africa, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 46: Biogen Financial Performance

Figure 47: Pfizer Financial Performance

Figure 48: Novartis Financial Performance

Figure 49: Sanofi Financial Performance

Figure 50: Teva Pharmaceutical Financial Performance


List Of Table

Table 1: Global Historic Market Growth, 2015-2019, USD Billion

Table 2: Global Forecast Market Growth, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 3: Global Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 4: Global Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 5: Global Neurodegenerative Disorder Therapeutics Market, Segmentation By Distribution, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 6: Global Neurodegenerative Disorder Therapeutics Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 7: Global Neurodegenerative Disorder Therapeutics Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 8: Asia-Pacific, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 9: Asia-Pacific, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 10: China, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 11: China, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 12: India, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 13: India, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 14: Japan, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 15: Japan, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 16: Australia, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 17: Australia, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 18: Indonesia, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 19: Indonesia, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 20: South Korea, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 21: South Korea, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 22: Western Europe, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 23: Western Europe, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 24: UK, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 25: UK, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 26: Germany, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 27: Germany, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 28: France, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 29: France, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 30: Eastern Europe, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 31: Eastern Europe, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 32: Russia, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 33: Russia, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 34: North America, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 35: North America, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 36: USA, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 37: USA, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 38: South America, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 39: South America, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 40: Brazil, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 41: Brazil, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 42: Middle East, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 43: Middle East, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 44: Africa, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 45: Africa, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 46: Biogen Financial Performance

Table 47: Pfizer Financial Performance

Table 48: Novartis Financial Performance

Table 49: Sanofi Financial Performance

Table 50: Teva Pharmaceutical Financial Performance

Licence Rights

  • Single User License (for access by one person)
  • Site License (for access of one office location of a company)
  • Corporate License (allow access by all staff of the company)

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

1) By Indication Type: Parkinson's Disease; Alzheimer's Disease; Multiple Sclerosis; Huntington Disease; Other Indication Types; 2) By Drug Type: N- methyl- D- aspartate Receptor; Selective Serotonin Reuptake Inhibitor; Dopamine Inhibitors; Other Drug Types; 3) By Distribution: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy


Companies

Biogen; Pfizer; Novartis; Sanofi; Teva Pharmaceutical; UCB; Hoffmann- La Roche Ltd; ACADIA Pharmaceuticals Inc.; Lundeck A/S; Boehringer Ingeiheim International GmbH; Merck Serono; Orion Pharma Ltd; Mitsubishi Tanabe Pharma America; Allergan; GlaxoSmith Kline PLC; AbbVie; Eli lilly; Celgene; Neuro- Hitech Inc.; Bayer Schering Pharma AG; Amarin Corporation; AstraZeneca; Alector; Yumanity Therapeutics; Yangtze River Pharmaceutical Group; Chongqing Zein Pharmaceutical; Eisai

Company Profile

Company Profile Title

The neurodegenerative disorder therapeutics market consists of sales of neurodegenerative disorder therapeutics products and related services for neurodegenerative disorders. Neurodegenerative disorder is a range of incurable conditions that primarily affect the neurons of human brain and results in progressive degeneration or death of nerve cells. The neurodegenerative disorder therapeutics deals with the manufacturing and development of drugs and treatment that stops or slows down the neurodegenerative processes of diseases such as Parkinson's, Alzheimer's, Huntington's and other neurodegenerative disorders.
 
The global neurodegenerative disorder therapeutics market was worth USD 13.35 billion in 2019. It is expected to grow at a compound annual growth rate (CAGR) of 8.12% and reach USD 18.23 billion by 2023.
 
The neurodegenerative disorder therapeutics market has been geographically segmented into North America, Western Europe, Asia-Pacific, Eastern Europe, South America and Middle East & Africa. North America was the largest region in 2019 and Europe was the fastest growing region in 2019.
 
The neurodegenerative disorder therapeutics market covered in this report is segmented by indication type into Parkinson's disease, Alzheimer's disease, multiple sclerosis, Huntington disease, other indications. It is also segmented by drug type into n- methyl- d- aspartate receptor, selective serotonin reuptake inhibitor, dopamine inhibitors, others and by distribution into hospital pharmacy, retail pharmacy, online pharmacy.
 
Increased prevalence of neurodegenerative among the global population contributes to the growth of neurodegenerative disorder therapeutics market. The increase in the number of geriatric population, attributes to the increased prevalence of neurodegenerative disorders. According to World Population Prospects in 2017, the number of people above 60 years of age will increase from 962 million in 2017 to 2.1 billion in 2050 and it is expected that people aged over 80 years will triple from 137 million in 2017 to 425 million in 2050. According to the Alzheimer's Association, around 5.8 million Americans are suffering with Alzheimer disease and this number is projected to rise to around 14 million by 2050. The increased prevalence of neurodegenerative diseases among the ageing population increases the demand for neurodegenerative disorder therapeutics thereby driving the market.
 
High rates of failure in clinical trials and research and development (R&D) have always been a major challenge in the neurodegenerative disorder therapeutics market. Companies are continuously investing in R&D to develop treatments for neurodegenerative diseases but currently very few treatments are approved for neurodegenerative disorders. According to a study, researchers found out that between 2002 to 2012, only 244 compounds in 413 clinical trials for Alzheimer's disease passed through but only one compound was approved. This failure entitled Alzheimer's disease drugs to the highest rates of failure at 99.6% when compared to any other disease, including cancer, which has a failure rate at 81%. Moreover, as reported by The New England Journal of Medicine, in 2018, no new drug has been approved by the Food and Drug Administration (FDA) to treat Alzheimer's disease since 2013. The low rate of approval of neurodegenerative therapeutics have a negative impact on the market, hindering the growth of the market.
 
Manufacturers of neurodegenerative disorder therapeutics are undergoing various strategic partnerships with government and non- government organizations to discover and develop therapeutics for a range of neurodegenerative diseases. The companies in the neurodegenerative disorder therapeutics market are also increasing their collaboration with other players in the market in order to increase their capabilities for research and development activities in order to develop new and more effective therapeutic solutions to treat neurodegenerative disorders. For instance, from October 2019, Prevail Therapeutics Inc., a USA based biotechnology company and Lonza, a global supplier of pharma & Biotech and specialty ingredients based in Switzerland, collaborated to develop and manufacture gene therapy programs for patients of neurodegenerative diseases. Similarly, in February 2018, Abbevie, a USA based biopharmaceutical company and Voyager Therapeutics, a clinical stage gene therapy company based in USA, underwent a global strategic collaboration to develop and commercialize treatments for Alzheimer's disease and other tau-related (a protein) neurodegenerative diseases.
 
In January 2020, Biogen Inc., an America Biotechnology company acquired a novel clinical stage asset, PF-05251749 alongwith the applications from Pfizer for USD 75 million. The acquisition of the asset is expected to strengthen Biogen's existing pipeline of potential disease-modifying therapies in Alzheimer's and Parkinson's diseases since PF-05251749 is a CNS- penetrant regulator that has the potential to treat behavioral and neurological symptoms across various psychiatric and neurological diseases. Pfizer Inc., is a multinational pharmaceutical company based in the USA.
 
Major players in the market are Biogen, Pfizer, Novartis, Sanofi, Teva Pharmaceutical, UCB, Hoffmann- La Roche Ltd, ACADIA Pharmaceuticals Inc., Lundeck A/S and Boehringer Ingeiheim International GmbH.
READ MORE

Scope

1. Executive Summary

2. Neurodegenerative Disorder Therapeutics Market Characteristics

3. Neurodegenerative Disorder Therapeutics Market Size And Growth

3.1. Global Neurodegenerative Disorder Therapeutics Historic Market, 2015-2019, USD Billion

3.1.1. Drivers Of The Market

3.1.2. Restraints On The Market

3.2. Global Neurodegenerative Disorder Therapeutics Forecast Market, 2019-2023F, 2025F, 2030F, USD Billion

3.2.1. Drivers Of The Market

3.2.2. Restraints On the Market

4. Neurodegenerative Disorder Therapeutics Market Segmentation

4.1. Global Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Parkinson's Disease

Alzheimer's Disease

Multiple Sclerosis

Huntington Disease

Other Indication Types

4.2. Global Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

N- methyl- D- aspartate Receptor

Selective Serotonin Reuptake Inhibitor

Dopamine Inhibitors

Other Drug Types

4.3. Global Neurodegenerative Disorder Therapeutics Market, Segmentation By Distribution, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

5. Neurodegenerative Disorder Therapeutics Market Regional And Country Analysis

5.1. Global Neurodegenerative Disorder Therapeutics Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

5.2. Global Neurodegenerative Disorder Therapeutics Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

6. Asia-Pacific Neurodegenerative Disorder Therapeutics Market

6.1. Asia-Pacific Neurodegenerative Disorder Therapeutics Market Overview

6.2. Asia-Pacific Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

6.3. Asia-Pacific Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

7. China Neurodegenerative Disorder Therapeutics Market

7.1. China Neurodegenerative Disorder Therapeutics Market Overview

7.2. China Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,USD Billion

7.3. China Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,USD Billion

8. India Neurodegenerative Disorder Therapeutics Market

8.1. India Neurodegenerative Disorder Therapeutics Market Overview

8.2. India Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

8.3. India Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

9. Japan Neurodegenerative Disorder Therapeutics Market

9.1. Japan Neurodegenerative Disorder Therapeutics Market Overview

9.2. Japan Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

9.3. Japan Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

10. Australia Neurodegenerative Disorder Therapeutics Market

10.1. Australia Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

10.2. Australia Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

11. Indonesia Neurodegenerative Disorder Therapeutics Market

11.1. Indonesia Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

11.2. Indonesia Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

12. South Korea Neurodegenerative Disorder Therapeutics Market

12.1. South Korea Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

12.2. South Korea Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

13. Western Europe Neurodegenerative Disorder Therapeutics Market

13.1. Western Europe Neurodegenerative Disorder Therapeutics Market Overview

13.2. Western Europe Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

13.3. Western Europe Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

14. UK Neurodegenerative Disorder Therapeutics Market

14.1. UK Neurodegenerative Disorder Therapeutics Market Overview

14.2. UK Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

14.3. UK Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

15. Germany Neurodegenerative Disorder Therapeutics Market

15.1. Germany Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

15.2. Germany Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

16. France Neurodegenerative Disorder Therapeutics Market

16.4. France Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

16.5. France Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

17. Eastern Europe Neurodegenerative Disorder Therapeutics Market

17.1. Eastern Europe Neurodegenerative Disorder Therapeutics Market Overview

17.2. Eastern Europe Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

17.3. Eastern Europe Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

18. Russia Neurodegenerative Disorder Therapeutics Market

18.1. Russia Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

18.2. Russia Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

19. North America Neurodegenerative Disorder Therapeutics Market

19.1. North America Neurodegenerative Disorder Therapeutics Market Overview

19.2. North America Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

19.3. North America Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

20. USA Neurodegenerative Disorder Therapeutics Market

20.1. USA Neurodegenerative Disorder Therapeutics Market Overview

20.2. USA Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

20.3. USA Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

21. South America Neurodegenerative Disorder Therapeutics Market

21.1. South America Neurodegenerative Disorder Therapeutics Market Overview

21.2. South America Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

21.3. South America Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

22. Brazil Neurodegenerative Disorder Therapeutics Market

22.1. Brazil Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

22.2. Brazil Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

23. Middle East Neurodegenerative Disorder Therapeutics Market

23.1. Middle East Neurodegenerative Disorder Therapeutics Market Overview

23.2. Middle East Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

23.3. Middle East Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

24. Africa Neurodegenerative Disorder Therapeutics Market

24.1. Africa Neurodegenerative Disorder Therapeutics Market Overview

24.2. Africa Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

24.3. Africa Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

25. Neurodegenerative Disorder Therapeutics Market Competitive Landscape And Company Profiles

25.1. Neurodegenerative Disorder Therapeutics Market Competitive Landscape

25.2. Neurodegenerative Disorder Therapeutics Market Company Profiles

25.2.1. Biogen

25.2.1.1. Overview

25.2.1.2. Products and Services

25.2.1.3. Strategy

25.2.1.4. Financial Performance

25.2.2. Pfizer

25.2.2.1. Overview

25.2.2.2. Products and Services

25.2.2.3. Strategy

25.2.2.4. Financial Performance

25.2.3. Novartis

25.2.3.1. Overview

25.2.3.2. Products and Services

25.2.3.3. Strategy

25.2.3.4. Financial Performance

25.2.4. Sanofi

25.2.4.1. Overview

25.2.4.2. Products and Services

25.2.4.3. Strategy

25.2.4.4. Financial Performance

25.2.5. Teva Pharmaceutical

25.2.5.1. Overview

25.2.5.2. Products and Services

25.2.5.3. Strategy

25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Neurodegenerative Disorder Therapeutics Market

27. Neurodegenerative Disorder Therapeutics Market Trends And Strategies

28. Neurodegenerative Disorder Therapeutics Market Future Outlook and Potential Analysis

29. Appendix

29.1. Abbreviations

29.2. Currencies

29.3. Research Inquiries

29.4. The Business Research Company

29.5. Copyright And Disclaimer

 


List Of Figure

Figure 1: Global Historic Market Growth, 2015-2019, USD Billion

Figure 2: Global Forecast Market Growth, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 3: Global Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 4: Global Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 5: Global Neurodegenerative Disorder Therapeutics Market, Segmentation By Distribution, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 6: Global Neurodegenerative Disorder Therapeutics Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 7: Global Neurodegenerative Disorder Therapeutics Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 8: Asia-Pacific, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 9: Asia-Pacific, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 10: China, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 11: China, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 12: India, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 13: India, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 14: Japan, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 15: Japan, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 16: Australia, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 17: Australia, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 18: Indonesia, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 19: Indonesia, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 20: South Korea, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 21: South Korea, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 22: Western Europe, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 23: Western Europe, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 24: UK, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 25: UK, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 26: Germany, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 27: Germany, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 28: France, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 29: France, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 30: Eastern Europe, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 31: Eastern Europe, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 32: Russia, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 33: Russia, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 34: North America, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 35: North America, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 36: USA, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 37: USA, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 38: South America, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 39: South America, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 40: Brazil, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 41: Brazil, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 42: Middle East, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 43: Middle East, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 44: Africa, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 45: Africa, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 46: Biogen Financial Performance

Figure 47: Pfizer Financial Performance

Figure 48: Novartis Financial Performance

Figure 49: Sanofi Financial Performance

Figure 50: Teva Pharmaceutical Financial Performance


List Of Table

Table 1: Global Historic Market Growth, 2015-2019, USD Billion

Table 2: Global Forecast Market Growth, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 3: Global Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 4: Global Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 5: Global Neurodegenerative Disorder Therapeutics Market, Segmentation By Distribution, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 6: Global Neurodegenerative Disorder Therapeutics Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 7: Global Neurodegenerative Disorder Therapeutics Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 8: Asia-Pacific, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 9: Asia-Pacific, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 10: China, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 11: China, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 12: India, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 13: India, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 14: Japan, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 15: Japan, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 16: Australia, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 17: Australia, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 18: Indonesia, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 19: Indonesia, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 20: South Korea, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 21: South Korea, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 22: Western Europe, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 23: Western Europe, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 24: UK, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 25: UK, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 26: Germany, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 27: Germany, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 28: France, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 29: France, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 30: Eastern Europe, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 31: Eastern Europe, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 32: Russia, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 33: Russia, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 34: North America, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 35: North America, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 36: USA, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 37: USA, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 38: South America, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 39: South America, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 40: Brazil, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 41: Brazil, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 42: Middle East, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 43: Middle East, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 44: Africa, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 45: Africa, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 46: Biogen Financial Performance

Table 47: Pfizer Financial Performance

Table 48: Novartis Financial Performance

Table 49: Sanofi Financial Performance

Table 50: Teva Pharmaceutical Financial Performance

  • Single User License (for access by one person)
  • Site License (for access of one office location of a company)
  • Corporate License (allow access by all staff of the company)
To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

1) By Indication Type: Parkinson's Disease; Alzheimer's Disease; Multiple Sclerosis; Huntington Disease; Other Indication Types; 2) By Drug Type: N- methyl- D- aspartate Receptor; Selective Serotonin Reuptake Inhibitor; Dopamine Inhibitors; Other Drug Types; 3) By Distribution: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy


Companies

Biogen; Pfizer; Novartis; Sanofi; Teva Pharmaceutical; UCB; Hoffmann- La Roche Ltd; ACADIA Pharmaceuticals Inc.; Lundeck A/S; Boehringer Ingeiheim International GmbH; Merck Serono; Orion Pharma Ltd; Mitsubishi Tanabe Pharma America; Allergan; GlaxoSmith Kline PLC; AbbVie; Eli lilly; Celgene; Neuro- Hitech Inc.; Bayer Schering Pharma AG; Amarin Corporation; AstraZeneca; Alector; Yumanity Therapeutics; Yangtze River Pharmaceutical Group; Chongqing Zein Pharmaceutical; Eisai